Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC + G-CSF Followed by Paclitaxel in High Risk Stage II/III Breast Cancer
NCT00001384Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- May 1994
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin, cyclophosphamide, filgrastim, paclitaxel in breast cancer, sponsored by National Cancer Institute. Started May 1994; status: completed.
02
Drugs
doxorubicincyclophosphamidefilgrastimpaclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00001384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00001384.